<DOC>
	<DOCNO>NCT00665808</DOCNO>
	<brief_summary>This NON INTERVENTIONAL OBSERVATIONAL STUDY conduct Europe . The purpose NON INTERVENTIONAL OBSERVATIONAL STUDY primarily investigate treatment satisfaction use Levemir® versus Protaphane® combination OADs daily setting .</brief_summary>
	<brief_title>Observational Study Treatment Satisfaction Levemir® Versus Protaphane® During `` Real-life '' Usage Germany</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Isophane insulin , beef</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<mesh_term>Isophane Insulin , Human</mesh_term>
	<mesh_term>Insulin , Isophane</mesh_term>
	<criteria>Written inform consent obtain patient first documentation treatment observational study . Type 2 diabetes mellitus Patients , intensify treatment long act insulin addition treatment oral antidiabetic agent , due insufficient blood glucose control No contraindication use Protaphane® Levemir®</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>